| Authors: |
Toporowska J; King's College London, London, UK., Kapoor P; OMass Therapeutics, Oxford, UK., Musgaard M; OMass Therapeutics, Oxford, UK., Gherbi K; OMass Therapeutics, Oxford, UK., Sengmany K; OMass Therapeutics, Oxford, UK., Qu F; OMass Therapeutics, Oxford, UK., Soave M; OMass Therapeutics, Oxford, UK., Yen HY; OMass Therapeutics, Oxford, UK., Hansen K; King's College London, London, UK., Jazayeri A; OMass Therapeutics, Oxford, UK., Hopper JTS; OMass Therapeutics, Oxford, UK. Jonathan.hopper@omass.com., Politis A; King's College London, London, UK. argyris.politis@manchester.ac.uk.; Faculty of Biology, Medicine and Health, School of Biological Sciences, The University of Manchester, Manchester, UK. argyris.politis@manchester.ac.uk.; Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK. argyris.politis@manchester.ac.uk. |
